Mettler-Toledo International Inc. MTD
Healthcare · Diagnostics & Research · Switzerland · S&P 500
Based on the available data, Mettler-Toledo International Inc. gets an algorithmic score of 54/100. It trades at 1,537.33 $, with a bullish technical trend (RSI 71.4) and 32.4% annual volatility.
Updated: 2026-09-30
Open in the interactive tool →
Strengths
- High net margin (21.9%): pricing power / competitive advantage.
Weaknesses
- High leverage (debt/equity 16668%): rate-sensitive.
Fundamentals
| P/E | 34.71 |
| Forward P/E | 29.74 |
| PEG | 2.77 |
| P/B | 2,402.08 |
| EV/EBITDA | 25.78 |
| P/S | 7.45 |
| ROA % | 21.10 |
| Gross margin % | 60.26 |
| Operating margin % | 31.20 |
| Net margin % | 21.91 |
| Revenue growth % (y/y) | 4.50 |
| Earnings growth % (y/y) | 18.30 |
| Revenue CAGR % | 0.90 |
| Earnings CAGR % | -0.13 |
| Debt/Equity % | 16,668.45 |
| Current ratio | 1.12 |
| FCF yield % | 2.76 |
| Dividend yield % | 0.00 |
| Payout % | 0.00 |
Returns
| 1 month | +9.9 % |
| 3 months | +20.3 % |
| 6 months | +23.2 % |
| YTD | +8.9 % |
| 1 year | +27.6 % |
| 3 years | +39.8 % |
| 5 years | +0.1 % |
Risk
| 1-year volatility | 32.4 % |
| Beta | 1.06 |
| 5-year max drawdown | -43.5 % |
| Sharpe 1A | 0.80 |
Macroeconomic context
Defensive with structural growth (ageing population). Risks: drug-pricing regulation, patents and clinical trials. Low correlation with the cycle.
How the score is calculated
The score combines profitability (ROE, ROA, net margin), growth (revenue and earnings), valuation (P/E, EV/EBITDA, free cash flow), financial strength (debt and liquidity; not applied to banks and insurers) and momentum (6 and 12-month returns and trend). It is an educational quantitative filter, not a buy or sell recommendation.